Cannabis use disorder clinical trials in Texas

Mental health

Also: Colorado

3 trials are recruiting with sites in Texas, according to ClinicalTrials.gov.

Checked against the registry on 5 October 2026. Listing a trial here is not a recommendation; taking part is voluntary and each study team decides who is eligible.

Recruiting · Phase 3 · Listed on Beacon

Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder

Ages 18 Years to 55 Years · 22 sites · in Texas: Austin, Houston · PleoPharma, Inc.

Details and how to check if you qualify · NCT07644052 on ClinicalTrials.gov

Not yet recruiting · Phase 1 / Phase 2

Pregnenolone for Cannabis Use Disorder and Depression

Ages 18 Years to 50 Years · 2 sites · in Texas: Dallas, Richardson · University of Texas Southwestern Medical Center

NCT07685964 on ClinicalTrials.gov

Recruiting · Phase 1 / Phase 2

Mitigating PTSD-CUD After Sexual Assault

Ages 18 Years to no maximum · 6 sites · in Texas: Austin · University of Nevada, Las Vegas

NCT05989841 on ClinicalTrials.gov

More: Acne clinical trials · Alzheimer’s disease and related dementias clinical trials · Chronic hives (chronic urticaria) clinical trials · COPD (chronic obstructive pulmonary disease) clinical trials · Depression (major depressive disorder) clinical trials · Moderately to severely active crohn's disease clinical trials